BioSpace News Archive

Deals

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) on September 14, 2018

Arrowhead Pharmaceuticals Inc. today announced that as an inducement to entering into employment with the Company, on September 14, 2018, the Board of Directors approved “inducement” grants to nine new employees under Rule 5635(c)(4) of the NASDAQ Marketplace Rules.

September 21, 2018
·
2 min read
Policy

Kratom Industry to Congress: Protect Safe, Natural Botanical Products and Consumer Choice in Pending Drug Legislation

Millions relying on botanicals to manage their well-being are threatened by 11th hour addition of new language in House Bill directed at Synthetic Opioids

September 21, 2018
·
2 min read
Drug Development

Janssen Announces Results of Esketamine Nasal Spray Phase 3 Study in Patients with Treatment-Resistant Depression

Study is one of five submitted to U.S. FDA by Janssen as part of its new drug application for esketamine nasal spray for treatment-resistant depression

September 21, 2018
·
12 min read
Policy

NEVRO HOLDINGS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Nevro Corp. - NVRO

ClaimsFiler reminds investors that they have until October 22, 2018 to file lead plaintiff applications in a securities class action lawsuit against Nevro Corp.

September 21, 2018
·
2 min read
Business

Axol Bioscience Opens US Office

Axol, the rapidly growing specialist in human cell culture, is delighted to announce it has opened a new operational hub in the US.

September 21, 2018
·
1 min read
Policy

Investigation launched into certain nitisinone capsules from Sweden

The Canada Border Services Agency (CBSA) announced today that it is launching an investigation into whether or not certain nitisinone capsules originating in or exported from Sweden are being sold at unfair prices in Canada.

September 21, 2018
·
2 min read
Deals

Kala Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) on September 17, 2018

Kala Pharmaceuticals, Inc. today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).

September 21, 2018
·
2 min read